Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 239 citing articles:

Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report
Sandra R. Klein, Ion A. Hobai
Canadian Journal of Anesthesia/Journal canadien d anesthésie (2023) Vol. 70, Iss. 8, pp. 1394-1396
Closed Access | Times Cited: 103
Incretin hormones and type 2 diabetes
Michael A. Nauck, Timo D. Müller
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1780-1795
Open Access | Times Cited: 82
Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
Toshiko Kobori, Yukiko Onishi, Yoko Yoshida, et al.
Journal of Diabetes Investigation (2023) Vol. 14, Iss. 6, pp. 767-773
Open Access | Times Cited: 81
Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs
Silviu Stanciu, Emilia Rusu, Daniela Miricescu, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 87-87
Open Access | Times Cited: 56
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration
Mark L. van Zuylen, Sarah E. Siegelaar, Mark P. Plummer, et al.
British Journal of Anaesthesia (2024) Vol. 132, Iss. 4, pp. 644-648
Closed Access | Times Cited: 43
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Qiyuan Keith Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 21
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Kariem El‐Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Anaesthesia (2025)
Open Access | Times Cited: 8
A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients
Mirna S. Abd El Aziz, Melanie Kahle, Juris J. Meier, et al.
Diabetes Obesity and Metabolism (2016) Vol. 19, Iss. 2, pp. 216-227
Closed Access | Times Cited: 136
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Michael A. Nauck, Manfredi Rizzo, A.B. Johnson, et al.
Diabetes Care (2016) Vol. 39, Iss. 9, pp. 1501-1509
Closed Access | Times Cited: 133
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
M. Lorenz, Francesca Lawson, David R. Owens, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 130
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Manfredi Rizzo, Dragana Nikolić, Angelo Maria Patti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 9, pp. 2814-2821
Closed Access | Times Cited: 129
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial
Julio Rosenstock, Bruno Guerci, M Hanefeld, et al.
Diabetes Care (2016) Vol. 39, Iss. 8, pp. 1318-1328
Open Access | Times Cited: 128
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 121
Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, et al.
Diabetes Care (2017) Vol. 40, Iss. 4, pp. 614-624
Open Access | Times Cited: 112
Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
Victoria E R Parker, Darren Robertson, Tao Wang, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 3, pp. 803-820
Open Access | Times Cited: 104
Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure
Muhammad Shahzeb Khan, Gregg C. Fonarow, Darren K. McGuire, et al.
Circulation (2020) Vol. 142, Iss. 12, pp. 1205-1218
Open Access | Times Cited: 101
The application of simple metrics in the assessment of glycaemic variability
L. Monnier, C Colette, David R. Owens
Diabetes & Metabolism (2018) Vol. 44, Iss. 4, pp. 313-319
Closed Access | Times Cited: 92
The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice
Laurie L. Baggio, John R. Ussher, Brent A. McLean, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 11, pp. 1339-1349
Open Access | Times Cited: 90
Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
Jessica A. Huthmacher, Juris J. Meier, Michael A. Nauck
Diabetes Care (2020) Vol. 43, Iss. 9, pp. 2303-2312
Closed Access | Times Cited: 79
Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control
Paul El Meouchy, Mohamad Wahoud, Sabine Allam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12305-12305
Open Access | Times Cited: 69
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
Johanna Helmstädter, Karin Keppeler, Leonie Küster, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 659-676
Open Access | Times Cited: 59
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control
Ryan J. Jalleh, Karen L. Jones, Christopher K. Rayner, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1981-1993
Open Access | Times Cited: 58
Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity
Mojca Jensterle, Simona Ferjan, Luka Ležaič, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 4, pp. 975-984
Open Access | Times Cited: 56
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis
Alessandro Villaschi, Giuseppe Ferrante, F. Cannata, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 6, pp. 898-909
Closed Access | Times Cited: 12
The role of glucagon‐like peptide‐1 receptor agonists in metabolic dysfunction‐associated steatohepatitis
Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2001-2016
Closed Access | Times Cited: 12

Scroll to top